Company intelligence / Profile preview

Nomir Medical Technologies

Waltham, Massachusetts, United Statesbloomberg.com ↗

Ownership: Private
Development stage: Other

Overview

Nomir developed the Noveon® optical energy device for treating bacterial and fungal infections such as onychomycosis. The company received multiple patents and at least two FDA clearances for its dual-wavelength device. However, it failed to prove commercial viability or safety/effectiveness in later years, leading to legal disputes and apparent cessation of operations.

Therapeutic areas: Infectious DiseasesOther
Modalities: DevicePhototherapy
Industry: Therapeutic Medical Devices

Partnerships

Selex Galileo Inc.

Beyond the preview

Go deeper on Nomir Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nomir Medical Technologies.

Explore the full profile